Development and validation of a dried plasma spot LC–MS/MS method for therapeutic monitoring of vancomycin and comparison with enzyme‐multiplied immunoassay
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Fernanda Ribeiro Vidal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil. Hauptthemen laut MEDLINE: Vancomycin, Tandem Mass Spectrometry. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Coordination of Improvement of Personal Higher Education-Brazil, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Vancomycin is used as an antimicrobial agent for the treatment of severe gram‐positive infections. The importance of therapeutic monitoring of antimicrobials has led to the development of more specific sample preparation techniques capable of identifying with accuracy the concentration of this substance in the organism. An aliquot of 10 μl of plasma was transferred to Whatman 903 paper and dried at room temperature. The extraction method was performed by cutting and transferring the paper to a microtube and adding sodium phosphate buffer and internal standard. The mixture was shaken and centrifuged, and a 5‐μl aliquot was injected into the analytical system. The optimization of the main parameters that can influence the extraction efficiency was performed using multivariate approaches to obtain the best conditions. The method developed was validated, providing coefficients of determination higher than 0.994 and a lower limit of quantification of 1 mg/L. Within‐ and between‐run precision ranged from 11.4 to 17.30% and from 6.65 to 13.51%, respectively. This method was successfully applied to 75 samples of patients undergoing vancomycin therapy. The method was rapid, simple, and environmentally friendly with satisfactory analytical performance and was advantageous over the laborious and time‐consuming methodologies used in therapeutic drug monitoring routine analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
- Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
ORCID-Profile: Fábio Souza Barbosa, Sarah Eller, Tiago Franco de Oliveira
Förderung
- Coordination of Improvement of Personal Higher Education-Brazil
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Vidal, F. R., Ossanes, D. S., Birk, L., Scheid, C., Barbosa, F. S., Dallegrave, E., Merib, J., Eller, S., & de Oliveira, T. F. (2023). Development and validation of a dried plasma spot LC–MS/MS method for therapeutic monitoring of vancomycin and comparison with enzyme‐multiplied immunoassay. Biomedical Chromatography. https://doi.org/10.1002/bmc.5586
Vancouver
Vidal FR, Ossanes DS, Birk L, Scheid C, Barbosa FS, Dallegrave E, et al. Development and validation of a dried plasma spot LC–MS/MS method for therapeutic monitoring of vancomycin and comparison with enzyme‐multiplied immunoassay. Biomedical Chromatography. 2023. doi:10.1002/bmc.5586
BibTeX
@article{Vidal2023,
author = {Vidal, Fernanda Ribeiro and Ossanes, Daniela Souza and Birk, Letícia and Scheid, Camila and Barbosa, Fábio Souza and Dallegrave, Eliane and Merib, Josias and Eller, Sarah and de Oliveira, Tiago Franco},
title = {Development and validation of a dried plasma spot LC–MS/MS method for therapeutic monitoring of vancomycin and comparison with enzyme‐multiplied immunoassay},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5586}
}
EUVIMED